| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |